Skip to main content
. 2023 Apr 7;16:17562864231164806. doi: 10.1177/17562864231164806

Table 1.

Demographic, PN phenotype, and clinical characteristics of 13 GFAP-IgG-positive patients.

Pt. no. Age (y) / sex Pattern of PN Symptoms of autonomic and cranial neuropathy CNS syndromes Electrodiagnostic studies Brain or spinal lesions Nerve root enhancement Treatment Max. mRS/last follow-up mRS
Axonal neuropathy Demyelinating neuropathy Abnormal F or H reflexes
1 29/M Sensorimotor axonal neuropathy Tachycardia, abdominal distension Meningoencephalomyelitis Yes No Yes Yes No Steroids, IVIG 5/3
2 55/M Sensorimotor axonal and demyelinating neuropathy Abdominal distension Encephalomyelitis Yes Yes No No Yes Steroids, IVIG 4/2
3 54/M Predominant motor axonal neuropathy Bradycardia Meningoencephalomyelitis Yes No Yes Yes NA Steroids, IVIG, PE 5/4
4 59/M Predominant motor axonal neuropathy None Meningoencephalomyelitis Yes No Yes Yes NA Steroids, IVIG 4/4
5 43/M Predominant motor axonal neuropathy Orthostatic hypotension, abdominal distension Meningoencephalomyelitis Yes No Yes Yes Yes Steroids, IVIG 5/4
6 29/F Predominant motor axonal neuropathy Hyperhidrosis, diplopia Meningoencephalitis Yes No Yes No NA Steroids 3/1
7 47/F Predominant motor axonal neuropathy None Encephalitis Yes No No Yes NA Steroids 2/1
8 68/M Motor axonal neuropathy Abdominal distension Meningoencephalomyelitis Yes No No Yes NA Steroids 5/2
9 48/M Motor axonal neuropathy Constipation, diarrhea, abdominal distension, hyperhidrosis Meningomyelitis Yes No Yes No Yes Steroids 4/1
10 35/M Motor axonal neuropathy None Meningoencephalomyelitis Yes No No No Yes Steroids, IVIG 3/1
11 36/F Sensorimotor neuropathy Abdominal distension Encephalomyelitis No No Yes No Yes Steroids 4/3
12 30/F Sensorimotor neuropathy Abdominal distension Meningoencephalomyelitis No No Yes Yes No Steroids, IVIG 3/0
13 30/M Sensorimotor neuropathy Diplopia Meningomyelitis No No No Yes NA Steroids 2/0

CNS, central nervous system; F, female; IVIG, intravenous immunoglobulins; M, male; Max., maximum; mRS, modified Rankin scale; NA, not available; PE, plasma exchange; PN, peripheral neuropathy; Pt., patient; y, years.